Bridge to Life Ltd.’s Post

This is life changing in the field of organ transplant!!

More fantastic results achieved using OrganOx’s technology. As companies approach the market, building a story around the health economics and impact is always a challenge, so it is fascinating to see the real (and in this case, greater) impact when the technology begins to be used at scale.

🌍 Will you be attending the DCD Congress and Consensus in Bucharest? 🩺 Our clinical and commercial leads, Matthias Pfister and Chris Stahle will also be there and would love to start a conversation! We are always looking for diverse perspectives from leading professionals like you and we invite you get in touch 📢 #LiverTransplantation #LiverResearch #Apersys #AcceleratingResearch

⭐ Let's explore the newest session format in the #EASLCongress programme: the Do's and Don'ts symposia! ❓ Have you ever wondered when to refer a patient for liver transplantation? ❓ What to do if your decompensated cirrhotic patient has a too low MELD for transplant? 💡 Come to find out with world renowned leaders in these sessions that will give you knowledge to take straight back to your clinic! https://lnkd.in/ei7dcixf

The Organ Procurement and Transplantation Network (OPTN) is a public-private partnership that manages the US organ donation and transplantation system and has been the subject of many congressional inquiries and oversight investigations due to chronic performance problems. Read on as we explore recent initiatives to modernize the #OPTN and look ahead to what’s next in oversight and reform. Authors: Julia Grabo | Erica Stocker | Karen Sealander

Effects of Ketone Body 3-Hydroxybutyrate on Cardiac and Mitochondrial Function During Donation After Circulatory Death Heart Transplantation #MitochondrialFunction #Donation #Transplantation #DCD #Heart

Critical review (DOI: 10.1016/j.hbpd.2024.01.003) suggests liver transplantation could serve as an alternative treatment for certain patients with peri-hilar cholangiocarcinoma, offering potentially better long-term survival compared to chemotherapy. Eligibility for liver resection or transplantation requires careful patient selection and should be performed at specialized centers, emphasizing a multidisciplinary approach to treatment. #LiverCancer #Transplantation #SurgicalOncology #PatientCare #ClinicalPractice

Today, we highlight the newsletter by one of our members, Organización Nacional de Trasplantes (ONT), with an editorial by Beatriz Domínguez-Gil. 💡In the latest edition of the Newsletter Transplant, readers can compare organ donation and transplantation activities between countries globally and by transplant type, in 2022 versus 2021 and 2020. 📈The data from 2020 highlights the profound impact of the COVID-19 pandemic, while 2021 and 2022 showed a progressive recovery, with a global increase in transplant activities of 13% and 9% respectively. The newsletter also features data from the Eurocet platform by BRAVEST member Centro Nazionale Trapianti, which includes information on the donation, procurement, processing, distribution and clinical use of tissues and cells. 🔗Access the full newsletter here: https://lnkd.in/drscG4Gp

In this case series, we describe the outcomes of six patients who were transitioned from UFH to bivalirudin during their course of VV ECMO support as a bridge to lung transplantation. https://buff.ly/4bDIudZ

Dr. Chloë Ballesté, Medical Director at DTI, has published an article in Hospital Healthcare Europe on how standardising organ donation and transplantation programs can close the gap successfully across Europe. Read the article to learn more about the key role training plays in achieving this positive outcome👉 https://lnkd.in/e5nbceTR